Use of an internal ribosomal entry site to express two genes from a dicistronic construct after retroviral infection of cytotoxic T cells. by Tafuro, S, Hourigan, C, Mcmichael, A, Bell, J, Moss, P

The structure of the human allo-ligand HLA-B*3501 in complex with a cytochrome p450 peptide: steric hindrance influences TCR allo-recognition. by Hourigan, C, Harkiolaki, M, Peterson, N, Bell, J, Jones, E, O'Callaghan, C

The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. by Purbhoo, M, Boulter, J, Price, D, Vuidepot, A, Hourigan, C, Dunbar, P, Olson, K, Dawson, S, Phillips, R, Jakobsen, B, Bell, J, Sewell, A

A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex. by Xu, X, Purbhoo, M, Chen, N, Mongkolsapaya, J, Cox, J, Meier, U, Tafuro, S, Dunbar, P, Sewell, A, Hourigan, C, Appay, V, Cerundolo, V, Burrows, SR, Mcmichael, A, Screaton, G

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party by Schuurhuis, G, Heuser, M, Freeman, S, Béné, M, Buccisano, F, Cloos, J, Grimwade, D, Haferlach, T, Hills, R, Hourigan, C, Jorgensen, J, Kern, W, Lacombe, F, Maurillo, L, Preudhomme, C, Van Der Reijden, B, Thiede, C, Venditti, A, Vyas, P, Wood, B, Walter, R, Döhner, K, Roboz, G, Ossenkoppele, G